$ENVB
Enveric Biosciences Inc
PRICE
$4.03 ▼-1.467%
Extented Hours
VOLUME
314,662
DAY RANGE
3.9501 - 4.25
52 WEEK
1.3 - 18.5
Key Metrics
Market Cap
8.21 M
Beta
1.92
Avg. Volume
11.61 M
Shares Outstanding
2.08 M
Yield
0%
Public Float
0
Next Earnings Date
Next Dividend Date
Company Information
Enveric Biosciences is a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines to improve quality of life for cancer patients. Initial indications include radiodermatitis, a common and often severe side effect of radiation therapy, and chemotherapy-induced neuropathy.
CEO: Brent Kelton
Website: https://ameri100.com/
HQ: 5000 Research Ct Ste 750 Suwanee, 30024-6608 Georgia
Related News